World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 61 3208 2958 274 265 195 15972

Kimberly Gilmour publications per year

The chart shows the history of publications by Kimberly Gilmour between 2000 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Kimberly Gilmour published across 26 years, from 2000 to 2025, averaging 9.3 papers a year. Output peaked at 26 publications in 2019. 33 of the 242 publications appeared in the last two years.

No. of publications
5 10 15 20 25
Bar chart. Horizontal axis: year, 2000 to 2025. Vertical axis: number of publications, 0 to 26. Peak 26 publications in 2019. 2000: 2 publications 2001: 3 publications 2002: 2 publications 2003: 1 publication 2004: 5 publications 2005: 4 publications 2006: 4 publications 2007: 3 publications 2008: 4 publications 2009: 2 publications 2010: 3 publications 2011: 5 publications 2012: 6 publications 2013: 15 publications 2014: 6 publications 2015: 12 publications 2016: 10 publications 2017: 12 publications 2018: 14 publications 2019: 26 publications 2020: 16 publications 2021: 20 publications 2022: 23 publications 2023: 11 publications 2024: 16 publications 2025: 17 publications
2000 2025

242 publications in total across all disciplines

View publications per year as a table
Kimberly Gilmour: publications per year, 2000 to 2025
Year Publications
2000 2
2001 3
2002 2
2003 1
2004 5
2005 4
2006 4
2007 3
2008 4
2009 2
2010 3
2011 5
2012 6
2013 15
2014 6
2015 12
2016 10
2017 12
2018 14
2019 26
2020 16
2021 20
2022 23
2023 11
2024 16
2025 17
Total 242
Download as CSV

Kimberly Gilmour publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kimberly Gilmour sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 192–201 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 195 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187 195
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Kimberly Gilmour D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kimberly Gilmour sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 60–61 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197 61
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Kimberly Gilmour is affiliated with Great Ormond Street Hospital in the United Kingdom. Their research spans multiple fields within medicine, with a particular focus on immunodeficiency, autoimmune disorders, gene therapy, and CAR-T cell therapies.

Gilmour's main fields of study include Medicine and Biochemistry, Genetics and Molecular Biology. Within these broad fields, their subfields of interest cover Infectious Diseases, Immunology, Genetics, Oncology, and Molecular Biology.

Their work addresses key topics such as Immunodeficiency and Autoimmune Disorders, CAR-T cell therapy research, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Virus-based gene therapy research, Immune Cell Function and Interaction, and SARS-CoV-2 detection and testing.

Key recent publications by Gilmour include:

  • Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies (2020, The Lancet)
  • The Human Phenotype Ontology in 2024: phenotypes around the world (2023, Nucleic Acids Research)
  • Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia (2023, New England Journal of Medicine)
  • Lentiviral gene therapy for X-linked chronic granulomatous disease (2020, Nature Medicine)
  • Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency (2021, New England Journal of Medicine)

Frequent co-authors collaborating with Gilmour include Stuart Adams, Louis Grandjean, Matthew Buckland, Claire Booth, and Adrian J. Thrasher. These collaborations reflect a strong network in clinical and translational immunology and gene therapy research.

Gilmour has published extensively in prominent journals and venues, notably:

  • Blood
  • New England Journal of Medicine
  • Journal of Clinical Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications

Best Publications

  • Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients

    Steven J. Howe;Marc R. Mansour;Kerstin Schwarzwaelder;Cynthia Bartholomae

  • Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus

    Rebekah M. Dedrick;Carlos A. Guerrero-Bustamante;Rebecca A. Garlena;Daniel A. Russell

  • Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells

    Waseem Qasim;Hong Zhan;Sujith Samarasinghe;Stuart Adams

  • Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

    H Bobby Gaspar;Kathryn L Parsley;Steven Howe;Doug King

  • Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.

    Sara Ghorashian;Anne Marijn Kramer;Shimobi Onuoha;Gary Wright

  • Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome

    Salima Hacein-Bey Abina;H. Bobby Gaspar;Johanna Blondeau;Laure Caccavelli

  • Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase–Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction

    H. Bobby Gaspar;H. Bobby Gaspar;Samantha Cooray;Samantha Cooray;Kimberly C. Gilmour;Kimberly C. Gilmour;Kathryn L. Parsley;Kathryn L. Parsley

  • X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease

    Claire Booth;Kimberly C. Gilmour;Paul Veys;Andrew R. Gennery

  • A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes.

    Yenan T. Bryceson;Daniela Pende;Andrea Maul-Pavicic;Kimberly C. Gilmour

  • Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.

    H. Bobby Gaspar;H. Bobby Gaspar;Emma Bjorkegren;Kate Parsley;Kate Parsley;Kimberly C. Gilmour;Kimberly C. Gilmour

  • Long-Term Persistence of a Polyclonal T Cell Repertoire After Gene Therapy for X-Linked Severe Combined Immunodeficiency

    H. Bobby Gaspar;Samantha Cooray;Samantha Cooray;Kimberly C. Gilmour;Kimberly C. Gilmour;Kathryn L. Parsley;Kathryn L. Parsley

  • Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo

    Kerstin Schwarzwaelder;Steven J. Howe;Manfred Schmidt;Manfred Schmidt;Martijn H. Brugman

  • Whole-genome sequencing of a sporadic primary immunodeficiency cohort

    Thaventhiran Jed.;H Lango Allen;O S Burren;W Rae

  • Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis

    Nichola Cooper;Kanchan Rao;Kimberly Gilmour;Lema Hadad

  • Lentiviral gene therapy for X-linked chronic granulomatous disease.

    Donald B. Kohn;Claire Booth;Elizabeth M. Kang;Sung-Yun Pai

  • Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient

    Waseem Qasim;Maurizia Brunetto;Adam J. Gehring;Shao-An Xue

  • Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome.

    Caroline A. Lindemans;Robert Chiesa;Persis J. Amrolia;Kanchan Rao

  • Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.

    Donald B. Kohn;Claire Booth;Kit L. Shaw;Jinhua Xu-Bayford

  • The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis

    Sebastian Fn Bode;Sandra Ammann;Waleed Al-Herz;Mihaela Bataneant

  • Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma

    Karin Straathof;Barry Flutter;Rebecca Wallace;Neha Jain

  • Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management

    C. Gholam;S. Grigoriadou;K. C. Gilmour;K. C. Gilmour;H. B. Gaspar;H. B. Gaspar

Frequent Co-Authors

Adrian J. Thrasher
Adrian J. Thrasher University College London
Siobhan O. Burns
Siobhan O. Burns University College London
Paul Veys
Paul Veys Great Ormond Street Hospital
Persis Amrolia
Persis Amrolia Great Ormond Street Hospital
Christine Kinnon
Christine Kinnon University College London
Austen Worth
Austen Worth Great Ormond Street Hospital
Nigel Klein
Nigel Klein University College London
H. Bobby Gaspar
H. Bobby Gaspar Great Ormond Street Hospital
Andrew R. Gennery
Andrew R. Gennery Newcastle University
David M. Sansom
David M. Sansom University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open up diverse career opportunities in healthcare and research. Many students begin by advancing their foundational nursing knowledge through online BSN programs for non nurses, which are designed to transition professionals into nursing roles efficiently.

Additionally, accelerated programs like the easiest ABSN programs to get into allow candidates to earn a Bachelor of Science in Nursing faster, preparing them for specialized fields such as immunology and infectious disease management.

For those starting their nursing career or seeking practical experience, looking into LPN schools easy to get into can be a strategic stepping stone. Licensed Practical Nurse programs typically offer a faster path into patient care roles, which can complement later immunology-focused study.

Finally, advancing to roles that allow for greater autonomy, like a nurse practitioner specializing in immunology-related fields, can be achieved by exploring which nurse practitioner program is easiest. Choosing accessible programs helps professionals quickly scale their careers and impact on patient health.

Best Scientists Citing Kimberly Gilmour

Trending Scientists

Recently Published Articles